A detailed history of Empire Financial Management Company, LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Empire Financial Management Company, LLC holds 16,000 shares of YMAB stock, worth $132,480. This represents 0.06% of its overall portfolio holdings.

Number of Shares
16,000
Holding current value
$132,480
% of portfolio
0.06%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024

BUY
$9.95 - $15.39 $159,200 - $246,240
16,000 New
16,000 $210 Million

Others Institutions Holding YMAB

About Y-mAbs Therapeutics, Inc.


  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $362M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Empire Financial Management Company, LLC Portfolio

Follow Empire Financial Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empire Financial Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empire Financial Management Company, LLC with notifications on news.